期刊文献+

二甲双胍对2型糖尿病大血管病变的防治研究进展 被引量:10

下载PDF
导出
摘要 心血管并发症是2型糖尿病主要并发症之一,也是2型糖尿病致死致残的首要原因。2型糖尿病及糖耐量异常与心血管疾病密切相关。新近大量基础和临床研究表明,一线降糖药物二甲双胍不仅有良好的降血糖作用,更值得关注的是还具有独立于降糖之外的抗动脉粥样硬化、保护大血管、降低糖尿病和心血管疾病发生率及致残致死率作用,这一有益作用通过其调脂、改善血压、改善胰岛素抵抗和高胰岛素血症以及抗炎等作用实现。
出处 《临床误诊误治》 2014年第1期107-111,共5页 Clinical Misdiagnosis & Mistherapy
  • 相关文献

参考文献36

  • 1Hu O Y, Pan C Y, Yu J M, et al. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey [J]. Eur Heart J, 2006,27(21):2573-2579.
  • 2许雯,时立新,朱大龙,李延兵,周智广,田浩明,罗佐杰,严励,曾龙驿,杨立勇,傅祖植,程桦,翁建平.初诊2型糖尿病患者血脂和血浆致动脉硬化指数特点及不同方式短期强化降糖对其影响——附382例分析[J].新医学,2010,41(3):151-156. 被引量:7
  • 3Hoffmann IS, Alfieri A B, Cubeddu L X. Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salT -sensitive Hispanics [J]. J Hum Hypertens, 2007,21 (7):571-578.
  • 4Kalogeropulos A, Georgiopulou V, Harris T B, et al. Gliycemic stayus and incident hear failure in elderly without history of diabetes mellitus: the health, aging, and body com-position study [J ]. J Card Fail, 2009,15 (7): 593-599.
  • 5Holman R R, Paul S K, Bethel M A, et al. 10-year follow-up of intensive glucose control in type 2 diabetes [J]. N Engl J Med, 2008,359(15):1577-1589.
  • 6McAlister FA, Eurich 0 T, Majumdar S R, et al. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy [J]. Eur J Heart Fail, 2008, 10 (7): 703-708.
  • 7Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral anti diabetes drugs: retrospective cohort study using UK general practice research database [J ]. BMJ, 2009,339: b4731.
  • 8Pantalone K M, Kattan M W, Yu C, et al. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonyIureas , a retrospective analysis [J]. Acta Diabetol, 2009, 46(2): 145-154.
  • 9Inzucchi S E, Masoudi FA, Wang Y, et al. Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project [J]. Diabetes Care, 2005, 28 (7): 1680- 1689.
  • 10Eurich D T, McAlister FA, Blackburn D F, et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review [J]. BMJ, 2007,335(7618):497.

二级参考文献139

共引文献78

同被引文献126

  • 1王伟东.5种药物治疗2型糖尿病的成本—效果分析[J].实用医技杂志,2006,13(11):1864-1865. 被引量:9
  • 2孙蓓,王宝利,梁东春,左爱军,郭刚,张镜宇.TNF-a与2型糖尿病胰岛素抵抗的关系[J].天津医科大学学报,2006,12(3):424-426. 被引量:17
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010)[J].中国糖尿病杂志,2012,20(1):1-36.
  • 5Rubino F,Schauer PR,Kaplan LM,et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action[J]. Annu Rev Med,2010,61:393-411.
  • 6Buchwald H,Avidor Y,Braunwald E,et al. Bariatric surgery: a systematic review and meta-analysis[J]. JAMA,2004,292(14):1724-37.
  • 7MacLean LD,Rhode BM,Nohr CW. Long- or short-limb gastric bypass[J]? J Gastrointest Surg,2001,5(5):525-30.
  • 8Ochner CN,Gibson C,Shanik M,et al. Changes in neurohormonal gut peptides following bariatrie surgery[J]. Int J Obes,2011,35(2): 153-66.
  • 9Wen CP,David Cheng TY,Tsai SP,et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians[J]. Public Health Nutr,2009,12(4):497-506.
  • 10Rubino F,Kaplan LM,Schauer PR,et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus[J]. Ann Surg,2010,251(3):399-405.

引证文献10

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部